All Stories

  1. Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 – April 2019

    Article • Human Vaccines & Immunotherapeutics, June 2022, Taylor & Francis

    Dr Adamantia Liapikou

  2. Outpatient Management of COVID-19 Disease: A Holistic Patient-Centered Proposal Based on the Greek Experience

    Article • Journal of Personalized Medicine, July 2021, MDPI AG

    Dr Adamantia Liapikou

  3. Systemic Inflammatory Response and Outcomes in Community-Acquired Pneumonia Patients Categorized According to the Smoking Habit or Presence of Chronic Obstructive Pulmonary Disease

    Article • Journal of Clinical Medicine, September 2020, MDPI AG

    Dr Adamantia Liapikou, Dr CATIA CILLONIZ

  4. The Burden of Community-Acquired Pneumonia Requiring Admission to an ICU in the United States

    Article • CHEST Journal, September 2020, Elsevier

    Dr Adamantia Liapikou

  5. Community acquired pneumonia: a cost-of-illness analysis in Greece

    Article • Rural and Remote Health, June 2020, Rural and Remote Health

    Dr Adamantia Liapikou

  6. Difficult to treat microorganisms in patients aged over 80 years with community-acquired pneumonia: the prevalence of PES pathogens

    Article • European Respiratory Journal, May 2020, European Respiratory Society (ERS)

    Dr Adamantia Liapikou, Dr CATIA CILLONIZ

  7. Advances in molecular diagnostic tests for pneumonia

    Article • Current Opinion in Pulmonary Medicine, May 2020, Wolters Kluwer Health

    Dr Adamantia Liapikou, Dr CATIA CILLONIZ

  8. Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: The PAIR study

    Article • Pulmonary Pharmacology & Therapeutics, February 2020, Elsevier

    Dr Adamantia Liapikou

  9. New antibiotics for community acquired pneumonia

    Article • Expert Opinion on Emerging Drugs, October 2019, Taylor & Francis

    Dr Adamantia Liapikou

  10. Risk and Prognostic Factors in Very Old Patients with Sepsis Secondary to Community-Acquired Pneumonia

    Article • Journal of Clinical Medicine, July 2019, MDPI AG

    Dr Adamantia Liapikou

  11. non invasive diagnosis of nosocomial pneumonia

    Article • Expert Review of Anti-infective Therapy, June 2019, Taylor & Francis

    Dr Adamantia Liapikou, Dr CATIA CILLONIZ

  12. lymphopenia predicts mortality in patients with ICU pneumonia

    Article • Journal of Clinical Medicine, June 2019, MDPI AG

    Dr Adamantia Liapikou, Dr CATIA CILLONIZ

  13. Drugs that increase the risk of community-acquired pneumonia: a narrative review

    Article • Expert Opinion on Drug Safety, September 2018, Taylor & Francis

    Dr CATIA CILLONIZ, Dr Adamantia Liapikou, antoni Torres

  14. Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia

    Article • European Respiratory Journal, March 2018, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ, Dr Adamantia Liapikou

  15. Investigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumonia

    Article • Expert Opinion on Investigational Drugs, October 2017, Taylor & Francis

    Dr Adamantia Liapikou, Dr CATIA CILLONIZ

  16. Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia

    Article • European Respiratory Journal, April 2016, European Respiratory Society (ERS)

    antoni Torres, Dr CATIA CILLONIZ, Dr Adamantia Liapikou

  17. The clinical management of lower respiratory tract infections

    Article • Expert Review of Respiratory Medicine, March 2016, Taylor & Francis

    Dr Adamantia Liapikou

  18. Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study

    Article • PLoS ONE, March 2016, PLOS

    Dr Adamantia Liapikou

  19. Tracheoesophageal fistula managed with tracheal stent through flexible bronchoscopy without fluoroscopy

    Article • Monaldi Archives for Chest Disease, February 2016, PAGEPress Publications

    Dr Adamantia Liapikou

  20. Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome

    Article • Critical Care, December 2015, Springer Science + Business Media

    Dr Adamantia Liapikou

  21. Ceftobiprole for the treatment of pneumonia: a European perspective

    Article • Drug Design Development and Therapy, August 2015, Dove Medical Press

    Dr CATIA CILLONIZ, Dr Adamantia Liapikou, antoni Torres

  22. ICS and risk of pneumonia

    Article • Expert Opinion on Drug Safety, June 2015, Informa Healthcare

    Dr Adamantia Liapikou

  23. Macrolide resistance and outcomes of patients with Streptococcus pneumoniae pneumonia.

    Article • American Review of Respiratory Disease, June 2015, American Thoracic Society

    Dr CATIA CILLONIZ, Dr Adamantia Liapikou

  24. Severe community-acquired pneumonia: Severity and management

    Article • Community Acquired Infection, January 2015, Medknow

    Dr CATIA CILLONIZ, Dr Adamantia Liapikou

  25. C-Reactive Protein at Discharge, Diabetes Mellitus and ≥1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, October 2014, Taylor & Francis

    Dr Adamantia Liapikou

  26. Pharmacotherapy for lower respiratory tract infections

    Article • Expert Opinion on Pharmacotherapy, September 2014, Informa Healthcare

    Dr Adamantia Liapikou

  27. SEVERE CAP IN THE ICU

    Article • Expert Review of Respiratory Medicine, May 2014, Taylor & Francis

    Dr Adamantia Liapikou

  28. NEW DRUGS FOR MRSA

    Article • Expert Opinion on Emerging Drugs, July 2013, Informa Healthcare

    Dr Adamantia Liapikou

  29. Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey

    Article • Critical Care, January 2013, Springer Science + Business Media

    Dr Adamantia Liapikou

  30. CAP IN COPD PATIENTS

    Article • European Respiratory Journal, September 2011, European Respiratory Society (ERS)

    Dr CATIA CILLONIZ, Dr Adamantia Liapikou

  31. PNEUMONIA RELATED TO MECHANICAL VENTILATION OR NOT

    Article • American Review of Respiratory Disease, December 2010, American Thoracic Society

    Dr Adamantia Liapikou

  32. VALIDATE THE GUIDELINES FOR HAP

    Article • Clinical Infectious Diseases, April 2010, Oxford University Press (OUP)

    Dr Adamantia Liapikou

  33. VALIDATION OF IDSA/ATS GUIDELINES FOR CAP

    Article • Clinical Infectious Diseases, February 2009, Oxford University Press (OUP)

    Dr Adamantia Liapikou

  34. Exclusive Diagnostic Contribution of the Histology Specimens Obtained by 19-Gauge Transbronchial Aspiration Needle in Suspected Malignant Intrathoracic Lymphadenopathy

    Article • CHEST Journal, January 2008, Elsevier

    Dr Adamantia Liapikou

  35. Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire

    Article • Clinical & Experimental Allergy, July 2005, Wiley

    Dr Adamantia Liapikou